ASR hip implants, rejected in U.S., still sold overseas (MassDevice)
A new report reveals that Johnson & Johnson continued overseas sales of its metal-on-metal ASR hip implants after the FDA rejected them for the U.S. market.
Johnson & Johnson's metal-on-metal hip implants stayed on the market in Europe and other countries after they were rejected for the U.S. market, according to a report from the New York Times.
The implants were sold to patients overseas for a year after they were prohibited for U.S. patients, until they were recalled in August 2010 amid concerns about high fai...
